NATHBIOGEN.BONATHBIOGEN.BO
LOADING
|||
EPS Growth Under Pressure
Trending lower, below historical average.
Left:
||||
Year-over-year earnings per share growth rate
Latest
-92.43%
↓ 152% below average
Average (39q)
178.44%
Historical baseline
Range
High:4011.11%
Low:-4234.46%
CAGR
NaN%
Modest growth trend
| Period | Value |
|---|---|
| Q3 2025 | -92.43% |
| Q2 2025 | 4011.11% |
| Q1 2025 | -66.17% |
| Q4 2024 | 150.94% |
| Q3 2024 | -96.98% |
| Q2 2024 | 1894.32% |
| Q1 2024 | 27.54% |
| Q4 2023 | -35.51% |
| Q3 2023 | -93.87% |
| Q2 2023 | 2197.37% |
| Q1 2023 | 7.04% |
| Q4 2022 | -7.79% |
| Q3 2022 | -95.24% |
| Q2 2022 | 126.44% |
| Q1 2022 | -4234.46% |
| Q4 2021 | 127.69% |
| Q3 2021 | -97.25% |
| Q2 2021 | 530.13% |
| Q1 2021 | 68.16% |
| Q4 2020 | 40.25% |
| Q3 2020 | -92.68% |
| Q2 2020 | 438.71% |
| Q1 2020 | 96.59% |
| Q4 2019 | 5.67% |
| Q3 2019 | -89.54% |
| Q2 2019 | 562.50% |
| Q1 2019 | 52.17% |
| Q4 2018 | -3.16% |
| Q3 2018 | -86.12% |
| Q2 2018 | 1388.04% |
| Q1 2018 | -62.75% |
| Q4 2017 | 11.26% |
| Q3 2017 | -82.39% |
| Q2 2017 | 1027.21% |
| Q1 2017 | -286.30% |
| Q4 2016 | 46.00% |
| Q3 2016 | -95.15% |
| Q2 2016 | 560.27% |
| Q1 2016 | -722.22% |
| Q4 2015 | 108.39% |